SpringWorks Therapeutics to Participate in the Jefferies London Healthcare Conference
SpringWorks Therapeutics (Nasdaq: SWTX) has announced its participation in the upcoming Jefferies London Healthcare Conference. The company's management will engage in a fireside chat on Tuesday, November 19, 2024, at 10:30 a.m. ET in London, UK. The event will be accessible via live webcast through the Events & Presentations page on SpringWorks' investor website. A replay will be available for a time after the conference.
SpringWorks Therapeutics (Nasdaq: SWTX) ha annunciato la sua partecipazione al prossimo Jefferies London Healthcare Conference. La direzione dell'azienda parteciperà a una chiacchierata informale martedì 19 novembre 2024, alle 10:30 ET a Londra, Regno Unito. L'evento sarà accessibile tramite webcast dal vivo attraverso la pagina Eventi e Presentazioni del sito web degli investitori di SpringWorks. Una riproduzione sarà disponibile per un certo periodo dopo la conferenza.
SpringWorks Therapeutics (Nasdaq: SWTX) ha anunciado su participación en la próxima Jefferies London Healthcare Conference. La dirección de la empresa participará en una charla informal el martes 19 de noviembre de 2024, a las 10:30 a.m. ET en Londres, Reino Unido. El evento estará disponible a través de una transmisión en vivo por el sitio de Eventos y Presentaciones en la página web de inversores de SpringWorks. Una repetición estará disponible por un tiempo después de la conferencia.
SpringWorks Therapeutics (Nasdaq: SWTX)은 다가오는 Jefferies London Healthcare Conference에 참여한다고 발표했습니다. 회사 경영진은 2024년 11월 19일 화요일 오전 10시 30분 ET에 영국 런던에서 진행되는 대화에 참석할 예정입니다. 이 행사는 SpringWorks 투자자 웹사이트의 이벤트 및 프레젠테이션 페이지를 통해 실시간 웹캐스트로 접근할 수 있습니다. 회의 후 일정 시간 동안 재생할 수 있는 녹화본이 제공될 예정입니다.
SpringWorks Therapeutics (Nasdaq: SWTX) a annoncé sa participation à la prochaine Jefferies London Healthcare Conference. La direction de l'entreprise participera à une discussion informelle le mardi 19 novembre 2024 à 10h30 ET à Londres, Royaume-Uni. L'événement sera accessible en direct via webcast à partir de la page Événements et Présentations sur le site des investisseurs de SpringWorks. Une rediffusion sera disponible durant un certain temps après la conférence.
SpringWorks Therapeutics (Nasdaq: SWTX) hat seine Teilnahme an der bevorstehenden Jefferies London Healthcare Conference angekündigt. Das Management des Unternehmens wird am Dienstag, den 19. November 2024, um 10:30 Uhr ET in London, UK, an einem Kamin-Gespräch teilnehmen. Die Veranstaltung wird über einen Live-Webcast auf der Seite Veranstaltungen und Präsentationen der Investoren-Website von SpringWorks zugänglich sein. Eine Aufzeichnung wird einen bestimmten Zeitraum nach der Konferenz verfügbar sein.
- None.
- None.
STAMFORD, Conn., Nov. 12, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference, taking place in London, United Kingdom on Tuesday, November 19, 2024 at 10:30 a.m. ET.
To access the live webcast, please visit the Events & Presentations page within the Investors & Media section of the company’s website at https://ir.springworkstx.com. A replay of the webcast will be available on SpringWorks’ website for a limited time following the conference.
About SpringWorks Therapeutics
SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer. OGSIVEO® (nirogacestat), approved in the United States for the treatment of adult patients with progressing desmoid tumors who require systemic treatment, is the Company’s first FDA-approved therapy. SpringWorks also has a diversified targeted therapy pipeline spanning solid tumors and hematological cancers, with programs ranging from preclinical development through advanced clinical trials. In addition to its wholly owned programs, SpringWorks has also entered into multiple collaborations with innovators in industry and academia to unlock the full potential for its portfolio and create more solutions for patients in need.
For more information, visit www.springworkstx.com and follow @SpringWorksTx on X (formerly Twitter), LinkedIn, and YouTube.
Contacts:
Investors
investors@springworkstx.com
Media
media@springworkstx.com
FAQ
When is SpringWorks Therapeutics (SWTX) presenting at the Jefferies London Healthcare Conference 2024?
How can I watch SpringWorks Therapeutics' (SWTX) presentation at the Jefferies Conference?
Will there be a replay available of SpringWorks Therapeutics' (SWTX) Jefferies Conference presentation?
What type of presentation will SpringWorks Therapeutics (SWTX) give at the Jefferies Conference?
